PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis

Willie Elliott(Illinois College), Kiran Kumar Velpula(Illinois College), Andrew J. Tsung(Illinois College), Durbaka V. R. Prasad(Yogi Vemana University), Teluguakula Narasaraju(University of Tennessee Health Science Center), Maheedhara R. Guda(Illinois College), Swapna Asuthkar(University of Illinois Urbana-Champaign)
Biomedicines
December 9, 2021
10.3390/biomedicines9121867
Cited by 29

Related Papers

B7-H3 role in the immune landscape of cancer.
|PubMed|2017|175
An overview of MCT1 and MCT4 in GBM: small molecule transporters with large implications.
|PubMed|2018|106
Glucose transport: meeting the metabolic demands of cancer, and applications in glioblastoma treatment.
|PubMed|2016|98
A potential role for Galectin-3 inhibitors in the treatment of COVID-19
|PeerJ|2020|90
Cancer stem cell molecular reprogramming of the Warburg effect in glioblastomas: a new target gleaned from an old concept
|CNS Oncology|2016|81